ADELANTE for HIV
Trial Summary
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It seems focused on a behavioral intervention rather than medication changes.
What data supports the effectiveness of the ADELANTE treatment for HIV?
Is the ADELANTE intervention generally safe for humans?
How is the ADELANTE treatment for HIV different from other treatments?
The ADELANTE treatment is unique because it involves community health workers (CHWs) delivering a problem-solving intervention to help people with HIV, focusing on increasing retention in care and improving viral suppression, especially in racial/ethnic minority communities. This approach is different from standard medical treatments as it emphasizes community-based support and counseling rather than just medication.28101112
What is the purpose of this trial?
The goal of this study is to test the effectiveness of ADELANTE on viral suppression among Latinos with HIV and viral non-suppression. Participants will receive ADELANTE (5-session, community health worker-delivered, problem-solving intervention) or enhanced care condition (ECC, 5 reminder phone calls). We will evaluate the overall effectiveness of ADELANTE compared with ECC on rates of viral suppression and emergency room visits and hospitalizations. Our hypothesis is that ADELANTE participants will achieve higher rates of viral suppression and will have lower rates of emergency room visits and hospitalizations compared with ECC at 12 months post-randomization.
Eligibility Criteria
This trial is for Latinos with HIV who are struggling to keep the virus under control. Participants will be randomly assigned to receive either a new intervention called ADELANTE, which includes five sessions with a community health worker, or an enhanced care condition involving five reminder phone calls.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Participants receive 5 individualized problem-solving sessions delivered by a community health worker over 6 months, framed around a bi-lingual film about HIV
Enhanced Care Condition
Participants receive 5 locator phone calls confirming contact information and routine HIV health promotion materials
Follow-up
Participants are monitored for viral suppression, emergency room visits, and hospitalizations
Treatment Details
Interventions
- ADELANTE
ADELANTE is already approved in United States for the following indications:
- Improving engagement in care for Latinos with HIV and viral non-suppression
Find a Clinic Near You
Who Is Running the Clinical Trial?
Massachusetts General Hospital
Lead Sponsor
Baylor College of Medicine
Collaborator
University of Miami
Collaborator